Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
F9dceZZp2duPZMb5
